Warning: The NCBI web site requires JavaScript to function. more...
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.
Solomon LA, Ali S, Banerjee S, Munkarah AR, Morris RT, Sarkar FH.
J Ovarian Res. 2008 Nov 24;1(1):9.
Related citations
Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line.
Li Y, Ellis KL, Ali S, El-Rayes BF, Nedeljkovic-Kurepa A, Kucuk O, Philip PA, Sarkar FH.
Pancreas. 2004 May;28(4):e90-5.
Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH.
Cancer Res. 2005 Aug 1;65(15):6934-42. Erratum in: Cancer Res. 2005 Dec 1;65(23):11228.
Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH.
Cancer. 2006 Mar 15;106(6):1260-8.
In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH.
Int J Cancer. 2007 Feb 15;120(4):906-17.
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
Cancer Res. 2005 Oct 1;65(19):9064-72.
The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy.
Sarkar FH, Adsule S, Padhye S, Kulkarni S, Li Y.
Mini Rev Med Chem. 2006 Apr;6(4):401-7. Review.
The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
Gynecol Oncol. 2004 Jul;94(1):67-73.
Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis.
Rocconi RP, Case AS, Straughn JM Jr, Estes JM, Partridge EE.
Cancer. 2006 Aug 1;107(3):536-43.
Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells.
Schneiderman D, Kim JM, Senterman M, Tsang BK.
Apoptosis. 1999 Aug;4(4):271-81.
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.
Mohammad RM, Al-Katib A, Aboukameel A, Doerge DR, Sarkar F, Kucuk O.
Mol Cancer Ther. 2003 Dec;2(12):1361-8.
A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.
Acta Oncol. 2001;40(2-3):340-60. Review.
Chemotherapy in recurrent epithelial ovarian cancer (EOC): an analysis of prognostic factors.
Shamsunder S, Kumar L, Gupta S, Kumar S, Bhatla N, Singh R, Kochupillai V.
J Obstet Gynaecol Res. 2000 Jun;26(3):215-22.
Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.
Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG.
BMC Cancer. 2006 Apr 26;6:107.
The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer.
Sellar GC, Watt KP, Li L, Nelkin BD, Rabiasz GJ, Porteous DJ, Smyth JF, Gabra H.
Int J Oncol. 2002 Nov;21(5):929-33.
Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG.
Cancer Res. 2007 Mar 1;67(5):2141-9.
Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Polyzos A, Kosmas C, Tsavaris N, Toufexi H, Lagadas A, Gogas H, Giannakopoulos K, Kouraklis G, Griniatsos J, Felekouras E, Tsigris C, Nikiteas N, Papadopoulos O, Giannopoulos A.
Anticancer Res. 2007 May-Jun;27(3B):1645-51.
Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line.
Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, Sarkar FH.
Pancreas. 2005 Nov;31(4):317-24.
Current treatment for ovarian cancer.
Eltabbakh GH, Awtrey CS.
Expert Opin Pharmacother. 2001 Jan;2(1):109-24. Review.
Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
Alici S, Saip P, Eralp Y, Aydiner A, Topuz E.
Am J Clin Oncol. 2003 Aug;26(4):358-62.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on